From Suppliers To Sloppiness, Experts Offer 5 Theories Why Aging Devices Are Recalled Most
• By Shawn M. Schmitt
A CDRH report recently showed that a majority of recalled devices are older, yet the center has provided little insight into how it came to its conclusion. FDA’s relative silence on the matter has left several industry insiders to deduce for themselves why aging product types struggle more with recalls than younger ones. One such expert believes a failure by manufacturers to understand their own products and evolving international standards play a role in the substantial number of older-device recalls. “I don’t think there’s any one thing you can say is causing this problem,” said Monica Wilkins, divisional VP of QA/RA for device-maker Abbott Labs. But in a time of increased global manufacturing and troubles keeping an eye on supply chains, it’s a safe bet that poor supplier control is a culprit.
When FDA’s device center began piecing together a first-of-its-kind report to uncover recall trends, it expected to discover that products in their infancy would comprise most of the recalls in a given year.
After a few years of data analysis, however, the group within CDRH tasked with the research discovered, to their great...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Research recently published in JAMA Internal Medicine found that the FDA met its review timeline goals for the majority of breakthrough devices – but also revealed some apparent shortcomings in safety data supporting the submissions.
Two recent recalls from the US FDA involve three deaths linked to an issue with an Abiomed heart pump — as well as three serious injuries related to angiographic catheters from Cook Medical.
The US FDA has issued an early alert to notify consumers about serious risks associated with a recall from Medtronic and its subsidiary Given Imaging. The alert concerns delivery capsules for diagnosing GERD.
After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.
Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.
“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.
